What Is MOP on a Drug Screen? What a Positive Result Means

MOP is the abbreviation for morphine on a standard drug screening panel. When a lab report lists “MOP,” it refers specifically to the test strip or immunoassay designed to detect morphine and closely related natural opiates in a urine sample. A positive MOP result does not automatically mean someone used heroin or was prescribed morphine, though. The test reacts to a family of substances, and the path from a positive screen to a definitive answer involves more steps than most people realize.

What MOP Detects and What It Misses

The antibodies used in a standard MOP immunoassay are built to recognize naturally occurring morphine. Because morphine is the core molecule that codeine and heroin also break down into, those substances will typically trigger a positive MOP result as well. Heroin, for instance, is rapidly metabolized into morphine in the body, so a MOP-positive screen is one of the main ways heroin use shows up on a drug test.

Where it gets tricky is with synthetic and semisynthetic opioids. Standard immunoassay tests contain antibodies for naturally occurring morphine and are less likely to bind to synthetic and semisynthetic opiates.1PubMed Central. Toxicologic Testing for Opiates: Understanding False-Positive and False-Negative Test Results That means drugs like fentanyl, methadone, tramadol, and buprenorphine usually will not show up on a MOP panel at all. Many people assume a “drug test for opioids” catches everything in that class, but MOP is narrower than that. If a testing program wants to detect fentanyl or methadone, it needs separate panels specifically designed for those drugs.

Oxycodone is a particularly confusing case. It is technically derived from opium constituents like morphine and codeine, yet many opiate screening assays poorly detect oxycodone and its metabolites.2Elsevier. A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing Someone taking oxycodone could easily produce a negative MOP result, which surprises both patients and clinicians. Hydrocodone falls into a similar gray area: some MOP assays pick it up at high concentrations, others do not. The takeaway is that MOP is reliable for morphine, codeine, and heroin metabolites, but unreliable or outright blind when it comes to many commonly prescribed pain medications.

How the Screening Works

The MOP panel on a standard urine drug screen uses an immunoassay, which is a fast, inexpensive test based on antibody reactions. A urine sample is exposed to antibodies that are designed to latch onto morphine molecules. If enough morphine (or a structurally similar molecule) is present in the sample, the test registers as positive. The whole process takes minutes, which is why immunoassays are the default for workplace testing, emergency departments, and substance-use treatment programs.

Immunoassays are intentionally designed to cast a wide net. They prioritize speed and sensitivity over precision. That speed comes with a tradeoff: the antibodies can cross-react with molecules that resemble morphine structurally but are not actually morphine. This is why a positive MOP screen is always considered preliminary. It tells you something opiate-related is present, but it cannot tell you exactly what or how much.

Cutoff Levels and Why They Matter

Every immunoassay has a cutoff level, a concentration threshold below which the test reports negative and above which it reports positive. For MOP, the federally mandated cutoff for workplace testing programs was lowered in 1998 to 2,000 ng/mL for both morphine and codeine. The original motivation was to reduce false positives from dietary poppy seed consumption. However, research showed that even after the cutoff was raised to that level, ingestion of common bakery products containing poppy seeds could still result in urine opiate concentrations at or above 2,000 ng/mL.3NCBI Bookshelf. Appendix B. Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use

Not all testing programs use the same cutoff. Clinical settings, pain management clinics, and substance-use treatment programs sometimes use lower thresholds, down to 300 ng/mL, to catch smaller amounts of opiate use. A lower cutoff makes the test more sensitive but also more prone to picking up traces from legitimate medications or food sources. If you are being tested for a job through a federally regulated program, the 2,000 ng/mL standard applies. If you are being monitored in a treatment program or a hospital, the cutoff may be considerably lower, and you should ask which threshold is being used.

The Poppy Seed Problem

Poppy seeds come from the same plant that produces opium, and they can carry trace amounts of morphine and codeine on their surface. This is not urban legend or internet folklore. It is a well-documented source of positive MOP results that has forced changes in federal testing policy. For programs identifying heroin or morphine intake by analyzing urine for morphine and codeine, medical review officers must rule out ingestion of poppy seeds as a source for the positive opiate test.4Elsevier. Morphine and Codeine Concentrations in Human Urine following Controlled Poppy Seeds Administration of Known Opiate Content

The amount of morphine on poppy seeds varies enormously depending on the seed source, processing method, and country of origin. Some commercially available poppy seeds contain enough morphine that a single serving on a bagel or in a pastry can push urine concentrations above the 2,000 ng/mL federal cutoff.3NCBI Bookshelf. Appendix B. Urine Collection and Testing Procedures and Alternative Methods for Monitoring Drug Use The morphine from poppy seeds typically appears in urine within two to three hours of eating them and can remain detectable for up to 24 to 48 hours, depending on the amount consumed and your metabolism.

If you know a drug test is coming, avoiding poppy seed products for at least three days beforehand is the simplest way to eliminate this as a complication. If you have already tested positive and you believe poppy seeds are the explanation, the confirmatory test and a conversation with the medical review officer are your best path to resolution.

Other Sources of Unexpected Positive Results

Poppy seeds get the most attention, but they are not the only reason someone might test MOP-positive without having used illicit drugs. Prescription medications are actually the more common explanation. Codeine-containing cough medicines, morphine prescribed for pain management, and codeine-based combination drugs (like those used for migraines or dental pain) all produce legitimate MOP-positive results. If you have a valid prescription, the medical review officer should clear the result once you provide documentation.

Cross-reactivity from non-opiate substances is rarer with MOP than with some other drug panels, but it does occur. Certain over-the-counter medications, including some formulations of dextromethorphan (a common cough suppressant), have been reported to cause weak positive results on some immunoassay platforms. The risk depends heavily on which manufacturer’s test kit is being used, because different antibody formulations have different cross-reactivity profiles. This is one of the reasons that a single positive immunoassay is never treated as a final answer in any credible testing program.

What Happens After a Positive MOP Screen

A positive MOP result on an immunoassay triggers confirmatory testing. The gold standard method uses gas chromatography followed by mass spectrometry, often abbreviated GC-MS. This technique physically separates molecules in the urine sample and then identifies each one by comparing its spectrographic signature to known standards. GC-MS allows for both identification and quantification of specific drugs and their metabolites, with sensitivity and specificity approaching 99%.1PubMed Central. Toxicologic Testing for Opiates: Understanding False-Positive and False-Negative Test Results

In practical terms, confirmatory testing can distinguish morphine from codeine, identify 6-monoacetylmorphine (a metabolite unique to heroin), and separate out any other substances that may have triggered the initial screen. If the initial immunoassay was a false positive caused by cross-reactivity or poppy seed consumption, GC-MS will catch it. This is why no reputable workplace testing program, treatment facility, or court should make a consequential decision based on an immunoassay alone.

Turnaround time for confirmatory testing is typically a few days, though it can take longer depending on the lab’s workload. During that waiting period, you are generally in limbo. In workplace programs, the result is reported as “pending” until the confirmation comes back and the medical review officer has weighed in.

The Medical Review Officer’s Role

In federally regulated drug testing, every confirmed positive result goes to a medical review officer (MRO) before it is reported to the employer or requesting agency. The MRO is a licensed physician trained specifically in interpreting drug test results. Their job is to determine whether a positive result has a legitimate medical explanation.

The MRO will contact you directly to ask about prescriptions, recent medical procedures, and any other factors that could explain the result. If you were prescribed codeine after a dental procedure, for example, and you provide pharmacy records or a note from your dentist, the MRO can report the result as “negative” with a medical explanation. If you claim poppy seeds caused the positive, the MRO will weigh that against the confirmation results. A confirmation showing only morphine and codeine in a ratio consistent with poppy seed ingestion, without the heroin-specific metabolite 6-monoacetylmorphine, supports that explanation.

The MRO process is far from rubber-stamp, though. A retrospective analysis of nearly 70,000 MRO evaluations in the US Army from 2009 through 2012 found that the unauthorized drug positive rate, meaning cases where no legitimate medical explanation could be established, was about 22%.5Journal of Analytical Toxicology. Unauthorized Drug Use in the US Army Based on Medical Review Officer Evaluations That means roughly three out of four positive results in that dataset were ultimately attributed to authorized medication use, poppy seed ingestion, or other legitimate explanations. The MRO process filters out a substantial proportion of results that would otherwise be misinterpreted.

Why MOP Is Not the Same as a Full Opioid Panel

One of the most common points of confusion is the assumption that “testing for opiates” means testing for all opioids. The MOP panel is an opiate screen, not an opioid screen, and that distinction matters. Opiates are the subset of opioids derived from the opium poppy: morphine, codeine, and heroin. Opioids is the broader term that includes synthetic drugs like fentanyl, methadone, and tramadol as well as semisynthetics like oxycodone and hydromorphone.

A standard five-panel drug test, the kind used in many workplace programs, includes MOP as one of its panels. It will catch morphine, codeine, and heroin but will miss fentanyl entirely. Given that fentanyl has become the dominant illicit opioid in many parts of the country, a MOP-only screening program has a significant blind spot. Many testing organizations have responded by adding dedicated fentanyl, oxycodone, and methadone panels to their standard offerings, but these are separate add-ons, not part of the MOP result.

If you are interpreting a drug screen report and you see MOP listed alongside abbreviations like OXY, FEN, or MTD, each of those is a separate immunoassay targeting a different drug. A negative MOP result alongside a positive FEN result means no morphine-class opiates were detected, but fentanyl was. They are independent measurements.

MOP in Pain Management and Addiction Treatment

Outside of workplace testing, MOP panels are used extensively in pain management clinics and substance-use disorder treatment programs. The purpose is different in each setting. Pain management clinics use the test to verify that patients are actually taking their prescribed medications and not diverting them (selling or giving them away). A patient prescribed morphine who consistently tests MOP-negative raises questions about adherence. A patient prescribed morphine who also shows unexpected positive results for other substances raises different questions.

In addiction treatment, MOP screening is used to monitor whether patients are abstaining from illicit opiate use. Programs that prescribe buprenorphine or methadone as medication-assisted treatment will often test for MOP specifically to check for unauthorized morphine or heroin use on top of the prescribed treatment medication. Because buprenorphine and methadone are synthetic and do not trigger MOP assays, a positive MOP result in that population typically indicates use of an outside opiate.

The interpretation challenges are amplified in these clinical settings because the cutoff levels are often much lower than in workplace testing. At a 300 ng/mL cutoff, even a modest amount of poppy seed exposure or residual codeine from a cough syrup can produce a positive result. Clinicians working in these settings learn to read MOP results in context, considering the patient’s medication list, recent dietary history, and the results of any confirmatory testing, rather than treating any single positive as conclusive evidence of relapse.

How Long Opiates Stay Detectable on a MOP Screen

Detection windows vary depending on the substance, the dose, your metabolism, your hydration level, and the test’s cutoff. For a single therapeutic dose of codeine or morphine, MOP screens typically detect the drug for one to three days after the last dose. Heroin metabolizes quickly into morphine and is usually detectable via MOP for a similar window. Chronic or heavy use extends the detection window, sometimes up to four or five days, because the drug accumulates in tissues and is released more slowly.

Hydration plays a meaningful role. A person who is well-hydrated will produce more dilute urine, potentially pushing morphine concentrations below the cutoff even when the drug is still present. Testing programs account for this by checking the creatinine concentration in each sample. If the creatinine level is unusually low, the sample may be flagged as dilute, and you may be asked to retest. Deliberately overhydrating before a test in hopes of diluting a positive result is a well-known tactic, and most testing programs have protocols specifically designed to catch it.

Body mass, liver function, age, and genetics also affect how quickly you clear opiates. Older adults and people with impaired kidney function tend to excrete morphine more slowly, which can extend the detection window. There is no single reliable number that applies to everyone, which is part of why interpretation always involves judgment rather than a simple chart.

When a Negative MOP Result Can Be Misleading

False negatives deserve as much attention as false positives. A person using oxycodone, fentanyl, or tramadol can test MOP-negative and be genuinely using opioids.2Elsevier. A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing In a clinical setting, this can create a false sense of reassurance. A patient with signs of opioid misuse who tests negative on a MOP screen has not been cleared of opioid use. They have been cleared of morphine-class opiate use specifically, and nothing more.

This gap has real consequences. Emergency physicians who rely on a standard urine drug screen to guide treatment decisions may miss fentanyl exposure entirely if the screen does not include a dedicated fentanyl panel. Pain management providers who only order MOP testing may not catch patients who are supplementing their prescribed opioid with a different one obtained elsewhere. The limitations of MOP are well understood in laboratory medicine, but they are often not communicated clearly to the clinicians and administrators who rely on the results. If you are a patient or a person being tested, knowing what MOP does and does not detect puts you in a better position to ask the right questions when a result comes back.